City
Epaper

Budget 2025 must introduce measures to drive innovation, manufacturing in health, pharma: Experts

By IANS | Updated: January 14, 2025 16:30 IST

New Delhi, Jan 14 The Union Budget 2025 must introduce transformative measures that drive innovation, manufacturing, and export ...

Open in App

New Delhi, Jan 14 The Union Budget 2025 must introduce transformative measures that drive innovation, manufacturing, and export competitiveness in healthcare and pharma sectors, said experts on Tuesday.

Finance Minister Nirmala Sitharaman will table the Union Budget 2025 in Lok Sabha on February 1.

While previous budgets have laid a strong foundation with initiatives like Production Linked Incentive (PLI) schemes and an increased R&D focus, the industry now looks forward to policies that further align with India’s ambition of becoming a $130B pharma market by 2030.

“This year’s expectations revolve around incentivising research, streamlining taxation frameworks, and fostering regulatory ease to bolster the sector’s growth and resilience in an evolving global landscape,” said Garima Malhotra, Associate Partner, Healthcare and Lifesciences at Praxis Global Alliance.

The expert pointed out the need to boost research and implored the government to increase investment into drug development parks, and research institutes and fostering academia-industry ties.

“We expect the government to introduce additional tax deductions, such as 1.25x for expenditures on training and skill development initiatives,” Malhotra said.

The industry also expects prioritising long-term financing solutions, including tax incentives, extended loan repayment periods, public-private partnerships, and the establishment of dedicated innovation zones.

The experts also stressed the need for strategic reforms in healthcare and life sciences to shape a resilient, inclusive healthcare system.

This includes key measures to streamline regulatory frameworks, accelerate R&D incentives, and introduce policies to facilitate the import of refurbished medical devices.

“Expanding import duty exemptions on life-saving drugs and oncology treatments will significantly reduce costs and enhance access. A commitment to increase public health spending to 2.5 per cent of GDP by 2025, alongside investments in rural healthcare infrastructure and a unified GST framework, will improve affordability across the system," said Munira Loliwala, VP- Strategy and Growth, TeamLease Digital.

Meanwhile, Poonam Muttreja, Executive Director of Population Foundation of India underscored the critical need to align fiscal policies and allocations with India's demographic trends, as well as investing in empowering our youth, advancing gender equality, and supporting our ageing population.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalIndia ‘embracing multi-alignment vigorously’ as relations with the US sour, says expert

MaharashtraMaratha Reservation Protest: BJP MLA Samadhan Awatade Seeks Special Legislature Session on Quota Issue

InternationalBrazilian President Lula says no immediate retaliatory tariffs against US, urges trade negotiations

Other SportsGujarat Home Minister Sanghavi credits PM Modi for boosting sports as Ahmedabad bids for 2030 Commonwealth Games

InternationalUS Justice Department announces probe into H-1B visa misuse

Health Realted Stories

HealthScientists uncover cellular "toolkit" to reprogram immune cells for cancer therapy: Study

HealthDelhi govt aiming to open 100 Ayushman Arogya Mandirs every month

HealthDelhi: NDMC inaugurates meditation centre at Kali Bari old age home

HealthSchizophrenia, depression may raise heart disease & death risks by nearly 100 pc: Study

HealthKerala setting up Rs 400 crore international Ayurveda research centre in Kannur: Veena George